Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment
Hutchinson-Gilford progeria syndrome (HGPS) is one of the most severe disorders among laminopathies—a heterogeneous group of genetic diseases with a molecular background based on mutations in the <i>LMNA</i> gene and genes coding for interacting proteins. HGPS is characterized...
Main Authors: | Katarzyna Piekarowicz, Magdalena Machowska, Volha Dzianisava, Ryszard Rzepecki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/2/88 |
Similar Items
-
Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo
by: Vera Wenzel, et al.
Published: (2012-04-01) -
Hutchinson–Gilford Progeria Syndrome: Clinical and Molecular Characterization
by: Pachajoa H, et al.
Published: (2020-09-01) -
The Molecular and Cellular Basis of Hutchinson–Gilford Progeria Syndrome and Potential Treatments
by: Noelle J. Batista, et al.
Published: (2023-02-01) -
Are There Common Mechanisms Between the Hutchinson–Gilford Progeria Syndrome and Natural Aging?
by: Vasily V. Ashapkin, et al.
Published: (2019-05-01) -
Vascular Smooth Muscle Cell-Specific Progerin Expression Provokes Contractile Impairment in a Mouse Model of Hutchinson-Gilford Progeria Syndrome that Is Ameliorated by Nitrite Treatment
by: Lara del Campo, et al.
Published: (2020-03-01)